Newswise — January 6, 2016 - The leading resource for cancer physical therapy and rehabilitation professionals, Rehabilitation Oncology, official journal of the Oncology Section of the American Physical Therapy Association (APTA), commences a publishing partnership with Wolters Kluwer with the January 2016 issue.
Rehabilitation Oncology becomes the seventh APTA section journal published by Wolters Kluwer. "We think that Section members and all oncology physical therapists will benefit from the significant enhancements to Rehabilitation Oncology and, even more important, the utility and accessibility of the evidence for practice published in the journal," comments Editor-in-Chief Lucinda (Cindy) Pfalzer, PT, PhD, FACSM, FAPTA.
Oncology Section members and subscribers will continue to receive Rehabilitation Oncology on its quarterly publication schedule, with the print edition featuring an attractive and streamlined design. In addition, readers will find an upgraded journal website, located at www.RehabOnc.com. Once registered, individual and institutional subscribers will be able to access the full contents of the journal—including the ability to search, read, and "favorite" any article, all the way back to the first issue in 1984.
The full-featured website can also be accessed on smartphones or other mobile devices through a responsive mobile version. The new website also offers a streamlined electronic manuscript submission, review, and tracking process. To learn about submitting, visit http://www.editorialmanager.com/rehabonc.
As always, Rehabilitation Oncology will present the most important new research, reviews, and perspectives on physical therapy and rehabilitation for patients with cancer. Highlights of the January issue include:• A new study on quality-of-life issues in children with severe chronic neutropenias• A timely review and meta-analysis on efficacy of self-management programs for managing side effects of breast cancer• EDGE Task Force reviews on clinical outcome measures related to prostate cancer and quality of life and colorectal cancer and muscle strength and endurance.
"Thanks to the hard work and dedication of our authors and reviewers, this issue includes important new work for all professionals involved in oncology physical therapy and cancer rehabilitation," Cindy Pfalzer adds. "More than ever, Oncology Section members will find Rehabilitation Oncology an invaluable resource for their clinical expertise and professional growth."
About Rehabilitation OncologyRehabilitation Oncology is the official quarterly publication of the Oncology Section of the American Physical Therapy Association. The journal is the primary peer-reviewed, indexed resource for advancing oncologic physical therapy practice and cancer rehabilitation through the dissemination of definitive evidence, translation of clinically relevant knowledge, and integration of theory into education, practice, and research.
About the Oncology SectionThe Oncology Section of APTA advances physical therapist practice to maximize the lifelong health, well-being and function of persons affected by cancer and HIV. The association consists of professional Physical Therapists managing the musculoskeletal, neuromuscular, integumentary and cardiopulmonary rehabilitative needs of patients resulting from the treatment of active cancer disease. This encompasses acute secondary sequela of cancer treatments such as surgery, radiation therapy, and chemotherapy; long-term secondary sequela of said treatments and palliative care.
About Wolters KluwerWolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
RSS